Accolade Inc. (ACCD)
NASDAQ (NGS) NASDAQ (NGS) Primary 
Investors In ACCD Can Join The Securities Fraud Investigation Of Accolade, Inc
LOS ANGELES, CA / ACCESSWIRE / July 2, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Nike, Accolade And Other Big Stocks Moving Lower In Friday's Pre-Market Session
U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 0.2% on Friday.
Accolade Stock Sinks After Earnings. The Case to Buy the Dip.
The tech and health company's fiscal-year earnings report weighs on shares.
Accolade: Mixed Guidance (Rating Downgrade)
Accolade's full-year guidance was mixed, notwithstanding a Q1 FY 2025 results beat driven by a favorable timing factor. ACCD sees its revenue growth slowing from +14% last year to +13% in the current fiscal year, but its 3.7% FY 2025 EBITDA margin guidance was above expectations. My rating for Accolade is downgraded from a Buy to a Hold, after considering the company's outlook in light of its updated guidance.
Accolade, Inc. (ACCD) Q1 2025 Earnings Call Transcript
Accolade, Inc. (NASDAQ:ACCD ) Q1 2025 Earnings Conference Call June 27, 2024 4:30 PM ET Company Participants Todd Friedman - SVP of IR Rajeev Singh - CEO Steve Barnes - CFO Conference Call Participants Richard Close - Canaccord Genuity Craig Hettenbach - Morgan Stanley Michael Cherny - Leerink Partners Jeff Garro - Stephens Inc. Ryan Daniels - William Blair Jailendra Singh - Truist Securities Jessica Tassan - Piper Sandler Ryan MacDonald - Needham & Company Stephanie Davis - Barclays Stan Berenshteyn - Wells Fargo David Larsen - BTIG Jack Wallace - Guggenheim Securities Operator Hello, and thank you for standing by. Welcome to the Accolade First Quarter 2025 Earnings Results Conference Call.
Accolade (ACCD) Reports Q1 Loss, Tops Revenue Estimates
Accolade (ACCD) came out with a quarterly loss of $0.35 per share versus the Zacks Consensus Estimate of a loss of $0.48. This compares to loss of $0.52 per share a year ago.
